Insiders · Profile

Patel Sujal M

CEO, President, and Secretary at Nautilus Biotechnology. Filing since 30 Nov 2021. CIK 0001378830

Company
Date
Role
Action
Shares
Amount
Of holding
4 Mar 2026
CEO, President, and Secretary
Bought
25,000
$65.24K
0.2%
8 Sep 2025
CEO, President, and Secretary
Bought
83,500
$57.03K
0.8%
5 Sep 2025
CEO, President, and Secretary
Bought
116,500
$78.54K
1.1%
20 Mar 2025
CEO, President, and Secretary
Bought
23,933
$23.89K
0.2%
19 Mar 2025
CEO, President, and Secretary
Bought
53,300
$53.03K
0.5%
11 Mar 2024
CEO, President, and Secretary
Bought
12,044
$34.22K
0.1%
8 Mar 2024
CEO, President, and Secretary
Bought
2,430
$7.26K
0.0%
7 Mar 2024
CEO, President, and Secretary
Bought
18,854
$54.42K
0.2%
6 Mar 2024
CEO, President, and Secretary
Bought
9,267
$25.03K
0.1%
5 Mar 2024
CEO, President, and Secretary
Bought
7,405
$19.60K
0.1%
8 Aug 2022
CEO, President, and Secretary
Bought
8,346
$24.44K
0.1%
5 Aug 2022
CEO, President, and Secretary
Bought
41,654
$121.65K
0.4%
9 May 2022
CEO, President, and Secretary
Bought
50,000
$198.00K
0.5%
3 Mar 2022
CEO, President, and Secretary
Bought
50,000
$179.89K
0.5%
1 Dec 2021
CEO, President, and Secretary
Bought
88,022
$416.40K
0.9%
30 Nov 2021
CEO, President, and Secretary
Bought
161,978
$764.78K
1.7%
16 decisions on file.